News
2016
-
-
Sysmex, Astellas and Daiichi Sankyo Sign Memorandum of Understanding on the Creation of a Method for Analyzing Circulating Tumor Cells
-Engaging in Joint Research to Create New Cancer Diagnostic Value and Applying It to Drug Research-
-
-
Sysmex to Exhibit the RF-500 Flow Cytometer for the Research and Industrial Domains at the Molecular Biology Society of Japan and the Japanese Society for Immunology
-
-
Sysmex Signs Agreement with National Health Laboratory of Myanmar to Provide Scientific Support Activities Aimed at Enhancing the Quality of Clinical Testing
-
-
Sysmex Wins Awards in 2016 Kinki Local Commendations for Inventions
-
-
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2017 (PDF：875KB)
-
-
Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2016, and Revision of Full-Year Financial Results Forecasts (PDF：90KB)
-
-
Announcement Regarding Dividends from Surplus (Interim) and Revised Forecast for the Year-End Dividend (PDF：81KB)
-
-
Sysmex Receives “Eruboshi” Certification as an Excellent Company Based on the Act on Promotion of Women’s Participation and Advancement in the Workplace
-
-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the First Time
-
-
Sysmex’s Automated Blood Coagulation Analyzer Certified Under the 5th Heritage Program of Legacy Analytical Instruments/Scientific Instruments
-
-
Sysmex Wins the 14th Annual Merit Award from the Minister of Economy, Trade and Industry for Collaborative Achievement Between Industry, Academia and Government
-
-
Donation to “International Clinical Cancer Research Center” (provisional name) of Kobe University
-
-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2017 (PDF：857KB)
-
-
Sysmex Proposal for Laboratory Quality Control Support Project in the Republic of Namibia under JICA’s Collaboration Program with the Private Sector for Disseminating Japanese Technology
-
-
Sysmex, Healios and Sumitomo Dainippon Pharma Begin Joint R&D Related to Pre-Transplant Immune Reaction Testing Method for Retinal Pigment Epithelial Cells (RPE Cells) Derived from Allogeneic iPS Cells
-
-
Sysmex Pursuing Joint Development with GL-i to Provide New Diagnostic Reagents Employing Glycosylation Markers
-
-
Our Views and Policy regarding Investment Unit Reduction (PDF：75KB)
-
-
Sysmex Acquires Additional Shares in RIKEN GENESIS and Converts Company to a Subsidiary
-Reinforcing Our Structure Toward the Practical Realization of Genomic Medicine-
-
-
Announcement of Partial Revision of the Articles of Incorporation (PDF：74KB)
-
-
Sysmex Asia Pacific Establishes Branch in Myanmar
-Aiming to Help Raise the Level of Healthcare in Myanmar-
-
-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2016 (PDF：652KB)
-
-
Sysmex Announces Changes from Financial Results Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2016 (PDF：142KB)
-
-
Sysmex Records Loss on Valuation of Investments in Capital of Subsidiaries and Associates and Conducts Lump-Sum Amortization of Goodwill in Relation to Sysmex Inostics (PDF：83KB)
-
-
Announcement of Executive Change (PDF：57KB)
-
-
Sysmex Provides Donation for Kumamoto Earthquake Relief
-
-
Sysmex and Siemens Extend Long-standing Global Partnership in Hemostasis Testing
-
-
New Liquid Biopsy RAS Testing for metastatic colorectal cancer patients now available for clinical practices
-
-
Sysmex Signs Agreement with Mongolia’s Ministry of Health and Sports to Support Activities to Create External Quality Controls and a Reference Laboratory
-
-
Sysmex to Be Special Sponsor of the Kobe Marathon 2016
-We are pleased to have sponsored this exciting event since its inception in 2011-
-
-
Sysmex Begins Joint Development of Imaging FCM Products with Merck
-
-
Sysmex and JVCKENWOOD to Commence Joint Development of Diagnostic Instruments for Measurement of Exosomes
-
-
Announcement of Organizational and Personnel Changes (PDF：41KB)
-
-
FY2015 Nakatani Award and Research Grant Recipients Announced (PDF：131KB)
-
-
Sysmex to Transition to a Company with an Audit and Supervisory Committee (PDF：31KB)
-
-
Sysmex and Eisai enter comprehensive agreement to create next-generation diagnostic reagents in the field of dementia
-
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2016 (PDF：445KB)
-
-
Sysmex to Voluntarily Adopt International Financial Reporting Standards (IFRS) (PDF：24KB)
-
-
Sysmex Launches a New Product in the Sediment Urinalysis Testing Field, the UD-10 Fully-Automated Imaging Unit for Formed Elements in Urine
-
-
Sysmex Selected as One of 2016 Global 100’s Most Sustainable Companies in the World
-
-
Medicaroid Corporation’s US Subsidiary Commences Operations in Silicon Valley
-
-
Sysmex Enters Business Alliance Agreement with EIKEN CHEMICAL CO., LTD., Involving the Urine Chemistry Testing Business in Overseas Markets
-
-
Sysmex Launches the UC-3500 Fully-Automated Urine Chemistry Analyzer, its First Product in the Field of Urine Qualitative Analysis in Overseas Markets
